with all of the extracts were typical of those in previous experiments (5) . In a series of three experiments the various tissue extracts were added in concentrations of 0.5 and 1.0 per cent to the solid nutrient media. As compared with the control plates, there was a depression in the growth rate of the inoculant, and a regression in the size of its original area. In the experimental plates this was followed at the end of 3 days by markedly increased growth, emanating from the original area of inoculation, of a white variant which within 2 days was approximately 3.5 to 5 times greater in area than that in the control plates. The effects were most marked with brain extract.
A series of tests (7) (8) (9) (10) (11) designed to distinguish between pathogenic and nonpathogenic strains of Staphylococcus aureus, were conducted in triplicate on both the S and R forms. From the data in Table I it would appear that the white R variant is non-pathogenic. Tests for chromogenesis made at intervals during 2~ years show that the variant has never reverted to the original orange growth. Although none of the applied "in vitro" tests serves as a standard whereby a line of demarcation between virulence and avirulence can be drawn, some investigators maintain that negative reaction to a combination of these tests is a fairly accurate indication of non-pathogenicity (1, 3, (7) (8) (9) (10) (11) (12) (13) (14) .
In vivo Stmties.--To determine whether the avirulence of the white R variant could be maintained in vivo, mice, 3 to 5 months old, BBC strain, and albino, were used as test animals. From the 3 to 5 day old experimental plates, yellow organisms were obtained from the center of the inoculation area and white organisms from the stimulated outgrowth from this area. Each test animal was immediately injected subcutaneously with 1 ml. of saline containing 1 loopful of the organisms. The experiments were made in triplicate using 10 animals for the yellow and 10 for the white organisms in each experiment. Three days after injection of the yellow organism, the control animals developed a gradually ascending paralysis, with 70 per cent mortality by the 4th day. The remaining 30 per cent developed large abdominal abscesses and sloughs which persisted for 3 weeks. There was no mortality among the experimental animals receiving the white organisms. These animals did not develop paralysis, and only 20 per cent had small non-suppurative hemorrhagic abdominal lesions which disappeared by the 7th day. Cultures from the lesions in the survivors in each of the two groups of animals revealed organisms corresponding in type to those injected, evidence for the maintenance of the relative avirulence in vivo of the white R variant of the strain of Staphylococcus aureus used in these experiments.
Treatment of Staphylococcic Infections with Tissue Extracts
2~rocedure. Control AnimaIs.--In the following experiments extending over a period of 18 months, BBC and albino mice of the Rockland strain 3 to 6 months of age were used.
The strain of Staphylococcus aureus employed was one obtained from the drainage of an infection on the hand and the organisms were maintained in nutrient broth as culture medium. At the time of use for infecting mice, saline suspensions were prepared with t loopful of a 48 hour culture of the organism per cc. of saline. The LDso was 0.35 cc. Lesions developed within 1 to 3 days following subcutaneous injection into the ventral abdominal region and in the surviving animals required 9 to 30 days to heal. Abscess formation was followed by extensive sloughing and the appearance of signs of intoxication, listlessness, inability to eat, shaggy hair, cyanosis, paralysis of the limbs, and death within 5 to 6 days. Blood cultures made from animals dying then showed that death was due to the staphylococcus. Following intraperitoneal (0.25 and 0.S cc.) or intravenous (0.1 cc.) injection of the organisms there were no localized lesions, but a generalized reaction occurred characterized by roughened fur, listlessness, sluggishness, and reduced activity. Death occurred in these animals within 24 hours and in some instances within a few minutes following the injection. The survivors required 14 and 1S days for recovery.
Experimental Animals: Brain Extract.--Brain extract was given subcutaneously in the ventral abdominal region each day to mice for (1) prophylactic experiments 2 to 6 hours prior to infection with Staphylococcus aureus and (2) for therapeutic experiments on the 1st day that lesions developed following injection, usually after 1 to 3 days, or, in the case of intravenous and intraperitoneal infection, following the onset of the generalized reaction. Treatment was given daily in 50 rag. doses until the lesions healed completely, as judged by scabs dropping off leaving smooth new skin beneath, or until the animals appeared normal following a generalized reaction. In the therapeutic experiments the animals were divided into control and experimental groups only after the lesions or the generalized reaction occurred, in order to have animals with infections of similar degree of severity in each group. The oral effectiveness of brain extract was tested both therapeutically and prophylactically using S00 rag. per 24 hours administered at intervals of 6 hours, through a curved hypodermic needle with a blunt edge.
In another series of experiments the relative effectiveness of decreasing amounts of the brain extract was tested against staphylococcic infections grading from a 50 rag. dose of the brain extract down to 5 rag. daily in both a prophylactic and therapeutic series of experiments.
qThe control animals were injected each day with a volume of saline equivalent to that of the brain extract.
Results.--In 25 experiments (Table II) using 50 mg. of brain extract daily in the prophylactic treatment of subcutaneous staphylococcic infections (227 control and 223 experimental mice) all of the 25 per cent of the controls surviving the infection developed typical abscesses which required from 9 to 30 days to heal. The incidence of lesions in the 99 per cent surviving experimental animals was 63 per cent. The interval between injection of the organisms and the appearance of the abscesses was not significantly altered in the experimental animals. The abscesses, however, were atypical in appearance, consisting of small dry lesions which did not progress to the sloughing stage and which healed completely in time intervals ranging from 3 to 14 days. There was no paralysis or manifestation of toxic symptoms in the treated animals. In 11 therapeutic experiments using a total of 116 control and 116 experimental animals (Table III) , in which treatment was begun with 50 rag. of brain extract daily after the typical lesion following subcutaneous injection of Stapkylococcus aureus had developed, 87 per cent of the control animals and 3 per cent of the experimental animals died. The range of healing time for the surviving control animals was 14 to 26 days with typical toxic manifestations and for the experimental animals, 4 to 15 days, in the absence of symptoms of toxicity.
The results of treating intraperitoneal infections in 50 mice by subcutaneous injection of 50 rag. of brain extract per day, both prophylactically and therapeutically, are shown in Table IV. In the prophylactic series, two-thirds of the 30 control animals died and the survivors required 14 to 19 days to recover from the generalized reaction. Of the 30 experimental animals that received a single preliminary dose of 50 rag. of brain extract subcutaneously, followed by 50 rag. per day, one died (1185 BP; the other 9 animals in this group did not react to the injection of the organisms in any apparent way) and the remaining experimental animals seemed normal again within 3 to 8 days. In the therapeutic series, none of the 20 control animals survived the intraperitoneal injection of organisms; none of the experimental animals died and they appeared to be completely recovered within 3 to 5 days.
None of 35 experimental animals died that received Stapkylococcus aureus intravenously (Table V) and brain extract subcutaneously whether prophylacticaUy or therapeutically. The single survivor of the 35 control animals required 15 days for recovery from the generalized reaction. Three, 4, and 6 days were required for recovery of the experimental animals with the exception of one group prophylactically treated (10205 BP) in which there was an immediate generalized reaction of all of the animals to the intravenous injection, but within 15 to 30 minutes all had apparently recovered. Treatment was continued for 3 days in this group. All of the control animals died within 24 hours of inoculation.
In Table VI are given the results of using doses of brain extracts graded to as low as 5 mg. per day prophylactically in a series of 6 groups of 6 experimental animals each, and 1 group of 6 control animals. There was no mortality among the experimental animals until the amount of brain extract was reduced to 10 and 5 nag. per day, while the healing time was gradually lengthened with the daffy administration of smaller amounts. The single surviving control animal required 23 days for the healing of the lesion. In the therapeutic experiments of One unhealed on 22nd day.
the same series, there were no deaths in the 6 groups of 10 experimental animMs each, while all of~the 10 control animals died. The healing time with this, as with the prophylactic series, was gradually lengthened as the daily amount of brain extract injected was reduced. 
* All surviving control animals developed abscesses at site of injection; 3 experimental animals had slight sloughs at site of injection which healed within 11 days. § 0.25 cc. inoculant used. Experimental animals treated for 10 days. H 0.5 cc. inoculant used. Dry slough appeared at site of injection on day 9 in 3 animals; healed 11 days later.
The oral effectiveness of brain extract therapy for subcutaneous S~zphy-Iocor~ aur~ infections is demonstrated by the data in Table VII . None of the treated animals in either the prophylactic or the therapeutic series died. All of the controls for the therapeutic series died. The two surviving controls in the prophylactic series required 15 and 21 days for healing of the abscesses.
In the 10 experimental animals receiving a single prophylactic dose of 100 mg. of brain extract per os only one developed an abscess, which appeared 5 days after subcutaneous infection with Staphylococcus aureus; lesions developed in all of the control animals of this series on the 2nd day after infection.
Other Tissue Extracts.--Therapeutic tests on subcutaneous infections with the other beef tissue extracts--liver, spleen, heart, and kidneynwere accompanied by results less striking than those with brain extract (Table vln; 
(2-3)
Immediate reaction of all animah with improvement in 15-30 minutes. is Os) 4 (3-4)
Animals inoculated with 0.1 cc. of a 24 hour culture of organism. * All dead ~thin 24 hours of inoculations. :~ Treatment continued for 3 days. Fig. 1 ). There was no mortality when the spleen and the heart extracts were used, but a slightly longer time (7 to 12 and 5 to 16 days, respectively) was required for complete healing of the lesions than was the case with brain extract (3 to 15 days). The infection in animals treated with kidney extract, however, showed but slight improvement as compared with that of the controls and it was felt that the poor results in this case may have been due in some measure to the toxicity of the extract at the dosage used, since all animals treated with the kidney extract exhibited toxic manifestations immediately following injections of the material. The liver extract proved too toxic to warrant further investigation. Brain extract administered at intervals of 4 hours through a curved needle directly into the stomach, a total of 300 rag. per day being given. Staphylococcus aureus dose was 1.5 LD~. 
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Mechanism of Action of Tissue Extracts on Staphylococcus aureus in Vivo
The following investigations are concerned with the effects of the tissue extracts on toxin production by Staphylococcus aureus and on the action of the toxin.
Eztrads and Toxl, P~od~tio,.--Control tubes containing nutrient broth and experimental tubes containing nutrient broth plus 1.0 per cent brain extract were inoculated with ~qtaphyloco¢¢~ a u r~ and allowed to incubate for 48 hours. Both sets of tubes were then centrifuged slowly for 15 minutes at the end of which time the supernatant materials were subjected to several filtrations through Berkefeld filters.
To determine whether brain extract prevented the formation of toxin by Stapkylocv¢c~ a u r~ (15) , the experimental and control filtrates were injected into test mice. The control filtrate was divided into 2 parts and 1.0 per cent brain extract was added to one portion to eliminate any variable which might have been introduced by the presence of brain extract in the experimental filtrate. In two series of experiments 3 groups of 10 mice each were injected subcutaneously in the abdominal region with 0.5 ml. of each of the filtrates. Observations on necrosis, hemolysis, and death are recorded in Table IX . The control filtrate was markedly toxic both as to its power to necrose tissue and to produce hemolysis, while that
extracts against the infection is not due to a non-specific effect such as leukocytosis. Apparently, therefore, the effectiveness of brain extract in combatting Staphylococcus aureu$ infections in animals is due in great measure to the pre- vention of toxin formation and only slightly to action on the formed toxin. Experimental study of the r61e of the tissue extracts in the general immunologic picture is in progress.
Toxicity of Extracts
Since previous experiments indicated that extracts of brain and spleen were less toxic than those of heart and kidney, slightly higher dosage levels of the former were used in acute toxicity tests. The results demonstrate the greater toxicity of the heart and kidney extract (Table X) . Doses smaller than 500 mg. of brain and spleen extract, a dosage approximately equivalent to2 to 2.5 per cent of the body weight, did not kill the animal. Injections of the spleen extract were accompanied by evidence of toxicity in the form of weight loss. Heart and kidney extracts, in addition to producing marked weight loss, resuited in mortality with dosages as low as the 80 mg. level, an amount approximately only 0.3 per cent of the body weight.
The tests for chronic toxicity (Table XI) , likewise showed brain and spleen extracts to be the safer materials. The low mortality in animals receiving brain * Average weight, 20 gin. Daily injections, subcutaneously extract occurred only within the last few days of the 60 day experiment. Mortality from the use of spleen and heart extracts was greater than with brain, and occurrred in the third quarter of the experimental interval. Mortality with the spleen extract was somewhat lower than that for the heart extract even though it was given at a higher dosage level. The kidney extract produced 100 per cent mortality with both dosages within 40 days after beginning injections.
SUMMARY
1. The ability of alcoholic-precipitated extracts of beef tissue--brain, spleen, heart, and kidney--to stimulate the growth of Staphylococcus aureus, in vitro, and to convert the yellow S form to a white R variant with altered biochemical characteristics conforming to those of an avirulent organism, has been confirmed.
2. The avirulence of the white R variant has been established by tests in d~o on mice.
3. St~phylococc~, aureu¢ infections induced subcutaneously, intraperitoneally, and intravenously in mice responded favorably to brain extract following subcutaneous or oral administration. The mortality was 2 per cent in 4~ experhnental animals and 81 per cent in 448 control animals.
4. The extracts appeared equally efficient when used therapeutically (mortality 2 per cent of 162 experimental animals and 90 per cent in the control series) or prophylactically (mortality 2 per cent of 282 experimental animals and 76 per cent in 286 control mice). Extracts of brain and spleen were more effective than those of either heart or kidney.
5. Studies concerning the mechanism of action of the tissue extracts indicate that they prevented the formation of toxin by Staphylococcus aum~,~, and had but little effect on toxin actions.
6. Toxicity tests revealed that the brain and spleen extracts were relatively non-toxic, dosages equivalent to 2 per cent of the body weight being well tolerated. Kidney and heart extracts were much more toxic, producing mortality in dosages as low as 0.3 per cent of the body weight.
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